4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001144204-14-008844
CIK 0001335103operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 9:38 PM ET
Size
5.4 KB
Accession
0001144204-14-008844
Insider Transaction Report
Form 4
HUGHES EDWARD JOSEPH
Chief Financial Officer
Transactions
- Award
Stock Option
2010-10-05$116438.00/sh+77,625$9,038,499,750→ 77,625 totalExercise: $1.50From: 2010-10-05Exp: 2020-10-05→ Common Stock (77,625 underlying)
Footnotes (1)
- [F1]Represents shares vested as of February 10, 2014.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 9:38 PM ET
- Size
- 5.4 KB